The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos

Malaria Journal

Volumn 17, Issue 1, 2018, Pages

  Pongvongsa, Tiengkham ^a,b   Phommasone, Koukeo ^c   Adhikari, Bipin ^a,d   Henriques, Gisela ^a   Chotivanich, Kesinee ^a   Hanboonkunupakarn, Borimas ^a   Mukaka, Mavuto ^a,d   Peerawaranun, Pimnara ^a   Von Seidlein, Lorenz ^a,d   Day, Nicholas P J ^a,d   White, Nicholas J ^a,d   Dondorp, Arjen M ^a,d   Imwong, Mallika ^a   Newton, Paul N ^c,d   Singhasivanon, Pratap ^a   Mayxay, Mayfong ^c,d,e   Pukrittayakamee, Sasithon ^a,f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Savannakhet Provincial Health Department   (Laos)

^c MAHOSOT HOSPITAL   (Laos)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF HEALTH SCIENCES   (Laos)

^f Endocrine Society of Thailand   (Thailand)

Author keywords

Asymptomatic parasitaemia; Elimination; Laos; MDA; P. falciparum; Savannakhet

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ANTIPARASITIC THERAPY; ARTICLE; ASYMPTOMATIC INFECTION; CHILD; COMMON COLD; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; GASTRITIS; HEADACHE; HUMAN; INCIDENCE; LAOS; LIQUID FECES; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; MEDICATION COMPLIANCE; NAUSEA; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VOMITING; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; ASYMPTOMATIC INFECTIONS; CHILD; DRUG COMBINATIONS; FEMALE; HUMANS; INCIDENCE; LAOS; MALARIA, FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; MIDDLE AGED; PLASMODIUM FALCIPARUM; PREVALENCE; QUINOLINES; YOUNG ADULT;

EID: 85056115739     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-018-2541-9     Document Type: Article

References (22)

1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
2. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715-30.
3. Pongvongsa T, Ha H, Thanh L, Marchand RP, Nonaka D, Tojo B, et al. Joint malaria surveys lead towards improved cross-border cooperation between Savannakhet province, Laos and Quang Tri province, Vietnam. Malar J. 2012;11:262.
4. Phommasone K, Adhikari B, Henriques G, Pongvongsa T, Phongmany P, von Seidlein L, et al. Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos). Malar J. 2016;15:296.
5. Ministry of Health of Laos. National strategy for malaria control and pre-elimination 2011-2015. https://www.thehealthcompass.org/sites/default/files/project-examples/Lao%20PDR%20NMSP%202011-2015.pdf. Accessed 26 July 2018.
6. United States Agency for International Development (USAID). President's malaria initiative: Greater Mekong sub-region, Malaria operational plan FY 2017. https://reliefweb.int/sites/reliefweb.int/files/resources/fy-2017-greater-mekong-subregion-malaria-operational-plan.pdf (2017). Accessed 18 June 2018.
7. Adhikari B, Pell C, Phommasone K, Soundala X, Kommarasy P, Pongvongsa T, et al. Elements of effective community engagement: lessons from a targeted malaria elimination study in Lao PDR (Laos). Glob Health Action. 2017;10:1366136.
8. WHO. Malaria elimination strategy in the greater Mekong subregion. Geneva: World Health Organization. http://iris.wpro.who.int/bitstream/handle/10665.1/10945/9789290617181-eng.pdf. Accessed 26 July 2018.
9. ClinicalTrials.gov. Targeted Chemo-elimination (TCE) of malaria (TME). https://clinicaltrials.gov/ct2/show/NCT01872702?cond=targeted+malaria+elimination&rank=1 (2018). Accessed 26 Aug 2018.
10. Adhikari B, Phommasone K, Kommarasy P, Soundala X, Souvanthong P, Pongvongsa T, et al. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). Malar J. 2018;17:15.
11. Adhikari B, Phommasone K, Pongvongsa T, Kommarasy P, Soundala X, Henriques G, et al. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR. Malar J. 2017;16:424.
12. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitaemias. J Clin Microbiol. 2014;52:3303-9.
13. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81.
14. Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491-7.
15. Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016;15:523.
16. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
17. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.
18. Tripura R, Peto TJ, Nguon C, Davoeung C, Mukaka M, Sirithiranont P, et al. A controlled trial of mass drug administration to interrupt transmission of multi drug resistant falciparum malaria in Cambodian villages. Clin Infect Dis. 2018;67:817-26.
19. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis. 2016;214:1831-9.
20. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet. 2018;391:1916-26.
21. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop. 2010;114:177-83.
22. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000;356:1560-4.